Changes of metabolic profiles in urine after oral administration of quercetin in rats

被引:22
作者
An, Daizhi [2 ]
Zhang, Qi [1 ]
Wu, Shengmin [1 ]
Wei, Jingyu [2 ]
Yang, Jijun [2 ]
Dong, Fangting [1 ]
Yan, Xianzhong [1 ]
Guo, Changjiang [2 ]
机构
[1] Natl Ctr Biomed Anal, Beijing 100850, Peoples R China
[2] Inst Hyg & Environm Med, Tianjin 300050, Peoples R China
基金
中国国家自然科学基金;
关键词
Quercetin; Metabolomics; NMR; HPLC-MS; Urine; Rat; HUMAN PLASMA; METABONOMIC TECHNIQUES; DIETARY ISOFLAVONES; FLAVONOIDS; ANTIOXIDANT; H-1; TEA; IDENTIFICATION; INHIBITION; INJURY;
D O I
10.1016/j.fct.2010.03.019
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Quercetin has been studied extensively. However, its actions in vivo are not well understood. We investigated the overall metabolic changes in urine after oral quercetin administration in rats and try to provide useful information on the actions of quercetin in vivo. Rats were orally administered a single dose of quercetin aglycon (40 mg/kg body weight). Urine samples were collected and subjected to H-1 nuclear magnetic resonance (NMR)-based metabolomic analysis and high performance liquid chromatography-mass spectrometry (HPLC-MS). Significant changes of metabolic profiles were observed in urine after quercetin administration. Relative increase in the concentrations of choline, creatinine, dimethylglycine, hippurate, taurine, trimethylamine N-oxide and reduction in acetate, alanine, lactate were observed. The concentrations of citrate, 2-oxoglutarate and succinate increased in the 0-24 h period after treatment and decreased thereafter. Some peaks assignable to quercetin metabolites were found in the aromatic regions of H-1 NMR spectra. HPLC-MS analysis identified quercetin, methyl quercetin, quercetin sulfate, quercetin monoglucuronide, and methyl quercetin monoglucuronide in urine after administration of quercetin. Our current findings indicate that quercetin behaves not only as an antioxidant, but also a modulator for some metabolic processes in vivo. The active forms of quercetin present in the biofluids must be investigated further. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1521 / 1527
页数:7
相关论文
共 46 条
[1]   Bioavailability and metabolism of the flavonol quercetin in the pig [J].
Ader, P ;
Wessmann, A ;
Wolffram, S .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (07) :1056-1067
[2]   Tissue distribution of quercetin in pigs after long-term dietary supplementation [J].
Bieger, Juliane ;
Cermak, Rainer ;
Blank, Ralf ;
de Boer, Vincent C. J. ;
Hollman, Peter C. H. ;
Kamphues, Joseph ;
Wolffram, Siegfried .
JOURNAL OF NUTRITION, 2008, 138 (08) :1417-1420
[3]   Health effects of quercetin: From antioxidant to nutraceutical [J].
Boots, Agnes W. ;
Haenen, Guido R. M. M. ;
Bast, Aalt .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 585 (2-3) :325-337
[4]   Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships [J].
Cao, GH ;
Sofic, E ;
Prior, RL .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (05) :749-760
[5]   Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially [J].
Ciolino, HP ;
Daschner, PJ ;
Yeh, GC .
BIOCHEMICAL JOURNAL, 1999, 340 :715-722
[6]   Hippuric acid as a major excretion product associated with black tea consumption [J].
Clifford, MN ;
Copeland, EL ;
Bloxsidge, JP ;
Mitchell, LA .
XENOBIOTICA, 2000, 30 (03) :317-326
[7]   Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats:: implications for biomarker discovery [J].
Connor, SC ;
Wu, W ;
Sweatman, BC ;
Manini, J ;
Haselden, JN ;
Crowther, DJ ;
Waterfield, CJ .
BIOMARKERS, 2004, 9 (02) :156-179
[8]   FLAVONOIDS AS DNA TOPOISOMERASE ANTAGONISTS AND POISONS - STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
CONSTANTINOU, A ;
MEHTA, R ;
RUNYAN, C ;
RAO, K ;
VAUGHAN, A ;
MOON, R .
JOURNAL OF NATURAL PRODUCTS-LLOYDIA, 1995, 58 (02) :217-225
[9]  
Cotelle Nicole, 2001, Current Topics in Medicinal Chemistry, V1, P569, DOI 10.2174/1568026013394750
[10]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105